Morgan Stanley
TPST icon

Morgan Stanley’s Tempest Therapeutics TPST Stock Holding History

Morgan Stanley’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38K Hold
2,058
– – ﹤0.01% 7228
2025
Q4 		$5.91K Sell
2,058
-50
-2% -$354 ﹤0.01% 7022
2025
Q3 		$21.7K Buy
2,108
+1
+0% +$9 ﹤0.01% 6669
2025
Q2 		$14.3K Sell
2,107
-1,313
-38% -$9.33K ﹤0.01% 6761
2025
Q1 		$32.8K Buy
3,420
+1,115
+48% +$12.6K ﹤0.01% 6413
2024
Q4 		$25K Sell
2,305
-5,399
-70% -$69.7K ﹤0.01% 6506
2024
Q3 		$140K Buy
7,704
+2,878
+60% +$58.9K ﹤0.01% 5876
2024
Q2 		$137K Buy
4,826
+1,996
+71% +$86.4K ﹤0.01% 5843
2024
Q1 		$144K Sell
2,830
-2,065
-42% -$104K ﹤0.01% 5853
2023
Q4 		$280K Buy
4,895
+4,863
+15,197% +$230K ﹤0.01% 5821
2023
Q3 		$125 Sell
32
-4
-11% -$38 ﹤0.01% 7429
2023
Q2 		$591 Sell
36
-2
-5% -$50 ﹤0.01% 7362
2023
Q1 		$1.15K Sell
38
-5
-12% -$110 ﹤0.01% 7331
2022
Q4 		$644 Hold
43
– – ﹤0.01% 7529
2022
Q3 		$1K Hold
43
– – ﹤0.01% 7607
2022
Q2 		$1K Sell
43
-117
-73% -$4.55K ﹤0.01% 7707
2022
Q1 		$7K Buy
160
+21
+15% +$953 ﹤0.01% 7512
2021
Q4 		$10K Sell
139
-14
-9% -$1.93K ﹤0.01% 7473
2021
Q3 		$29K Buy
153
+97
+173% +$18.9K ﹤0.01% 6947
2021
Q2 		$8K Buy
56
+51
+1,020% +$11.5K ﹤0.01% 7299
2021
Q1 		$1K Hold
5
– – ﹤0.01% 7385
2020
Q4 		$2K Hold
5
– – ﹤0.01% 6903
2020
Q3 		$2K Sell
5
-42
-89% -$14.2K ﹤0.01% 6593
2020
Q2 		$16K Buy
47
+42
+840% +$16.8K ﹤0.01% 6055
2020
Q1 		$5K Sell
5
-60
-92% -$87.5K ﹤0.01% 6225
2019
Q4 		$85K Buy
65
+50
+333% +$70.5K ﹤0.01% 5700
2019
Q3 		$21K Buy
15
+12
+400% +$19.4K ﹤0.01% 5995
2019
Q2 		$6K Sell
3
-13
-81% -$38.3K ﹤0.01% 6276
2019
Q1 		$46K Buy
16
+14
+700% +$31K ﹤0.01% 5708
2018
Q4 		$3K Hold
2
– – ﹤0.01% 6381
2018
Q3 		$3K Sell
2
-1
-33% -$2.4K ﹤0.01% 6521
2018
Q2 		$7K Buy
3
+1
+50% +$2.63K ﹤0.01% 6376
2018
Q1 		$5K Buy
2
+1
+100% +$3K ﹤0.01% 6398
2017
Q4 		$4K Sell
1
-9
-90% -$37.8K ﹤0.01% 6364
2017
Q3 		$41K Sell
10
-26
-72% -$111K ﹤0.01% 5841
2017
Q2 		$163K Sell
36
-19
-35% -$80.4K ﹤0.01% 5441
2017
Q1 		$300K Buy
55
+2
+4% +$9.31K ﹤0.01% 5117
2016
Q4 		$239K Buy
53
+38
+253% +$473K ﹤0.01% 5284
2016
Q3 		$319K Buy
15
+7
+88% +$127K ﹤0.01% 4779
2016
Q2 		$126K Buy
8
+7
+700% +$160K ﹤0.01% 5138
2016
Q1 		$28K Sell
1
-2
-67% -$42.3K ﹤0.01% 5819
2015
Q4 		$78K Sell
3
-12
-80% -$396K ﹤0.01% 5531
2015
Q3 		$371K Buy
15
+13
+650% +$875K ﹤0.01% 4776
2015
Q2 		$199K Sell
2
-82
-98% -$7.51M ﹤0.01% 5235
2015
Q1 		$8.55M Buy
84
+32
+62% +$4.26M ﹤0.01% 2230
2014
Q4 		$6.76M Buy
52
+26
+100% +$1.9M ﹤0.01% 2431
2014
Q3 		$1.24M Buy
26
+24
+1,200% +$841K ﹤0.01% 3856
2014
Q2 		$47K Sell
2
-10
-83% -$236K ﹤0.01% 5788
2014
Q1 		$314K Buy
12
+9
+300% +$255K ﹤0.01% 4861
2013
Q4 		$78K Buy
+3
New +$82.3K ﹤0.01% 5439
2013
Q3 		– Sell
-4
Closed -$150K – 5386
2013
Q2 		$150K Buy
+4
New +$150K ﹤0.01% 4965

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's TPST Position: Q1 2026 in Review

Morgan Stanley held its Tempest Therapeutics (TPST) position steady in Q1 2026 at 2,058 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #7228.

Morgan Stanley first reported a position in TPST in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.55M in Q1 2015. 22 funds tracked by Wall St. Rank hold TPST as of Q1 2026.

  • Morgan Stanley held 2,058 shares of Tempest Therapeutics worth $3.38K as of Q1 2026.
  • Morgan Stanley left its Tempest Therapeutics share count unchanged in Q1 2026.
  • Tempest Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7228 holding.
  • Morgan Stanley first reported a position in Tempest Therapeutics in Q2 2013 and has held it in 51 quarters since.
  • Morgan Stanley's Tempest Therapeutics position peaked at $8.55M in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.